What do systematic reviews say?

Phytotherapy vs Another topical agent or placebo

• Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 320 participants
  Low

Phytotherapy vs Another topical agent or placebo

Phytotherapy probably leads to higher prostatitis symptoms: 'responders' Number of participants with a 25%… compared with placebo or other agents (moderate certainty).

• Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
  RR 1.78 [1.25, 2.52]
  3 studies · 224 participants
  Moderate

Phytotherapy vs Another topical agent or placebo

Phytotherapy showed no clear difference in adverse events compared with placebo or other agents (low certainty).

• Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
  RR 1.13 [0.54, 2.36]
  7 studies · 540 participants
  Low

Phytotherapy vs Another topical agent or placebo

• Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 48 participants
  Low

Phytotherapy vs Another topical agent or placebo

The review found no eligible studies for this question.

• Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Phytotherapy vs Another topical agent or placebo

The review found no eligible studies for this question.

• Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Serenoa repens in combination with other phytotherapy vs placebo or no intervention

Serenoa repens in combination with other phytotherapy showed no clear difference in urologic symptom scoreMeasured by IPSS scores (range 0 to 35)Higher… compared with placebo or no intervention (low certainty).

• Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 460 participants
  Low

Serenoa repens in combination with other phytotherapy vs placebo or no intervention

• Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 265 participants
  Very low

Serenoa repens in combination with other phytotherapy vs placebo or no intervention

Serenoa repens in combination with other phytotherapy showed no clear difference in adverse eventsCumulative incidence compared with placebo or no intervention (low certainty).

• Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement 2023 · Cochrane Headline outcomes only
  RR 0.91 [0.58, 1.41]
  4 studies · 481 participants
  Low